Lupus Foundation of America4d
Conduit Pharmaceuticals Partners with Charles River Laboratories to Evaluate AZD1656 for Lupus Treatment
Conduit Pharmaceuticals and Charles River Laboratories have announced a partnership to evaluate AZD1656, a glucokinase activator, in a preclinical model of systemic lupus erythematosus (SLE).
Lupus Foundation of America6d
New Study Finds Anifrolumab In Addition to Standard of Care Treatment is Effective at Reducing Organ Damage Accumulation
People with systemic lupus erythematosus (SLE) often face irreversible organ damage due to uncontrolled disease activity, frequent disease flares, and long-term glucocorticoid treatment. A recent ...
Lupus Foundation of America5d
Apply For Funding
The Lupus Foundation of America uses an electronic grant submission process. All applicants must submit their full application packages through the ProposalCentral online grants management system.
Lupus Foundation of America3d
2025 TCS New York City Marathon
Join the Lupus Foundation of America's Inaugural TCS New York City Marathon team as we Race to End Lupus on November 2, 2025. Apply now to join LFA's TCS New York City Marathon Team The Lupus ...
Lupus Foundation of America6d
April Fuller
April is a writer and editor who uses her skills to create insightful and compassionate educational materials that help people with lupus and other chronic illnesses. The Lupus Foundation of America ...